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Hormone-scnsitivc lipase (HSL) is inhibited in a non-competitive manner by olcoyl CoA, olcic acid and I?-monopalmitoylglyecrol, 50% inhibition 
being observed at concentrations of approx. 0.1 FM, 0.5 PM and 500 PM, respectively. HSL is a key enzyme in lipid metabolism, mobilising 
triacylglyccrol and cholesterol ester stores in several tissues. Feedback inhibition of HSL by oleoyl CoA and oleic acid may therefore prevent 
accumulation of free fatty acids and cholesterol in the cell, whereas 2-monoacylglyccrol may act as a feedback inhibitor if the capacity of 
monoacylglycerol lipase is exceeded. 
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1. INTRODUCTION 
Hormone-sensitive lipase (HSL) is responsible for the 
hydrolysis of triacylglycerols and cholesterol esters in 
several tissues (reviewed in [l]). It catalyses the rate- 
limiting step in lipolysis in adipose tissue [2] and cardi- 
omyocytes [3], whereas in adrenal cortex [4,5] and mac- 
rophages [6] its role is apparently to mobilise cholesterol 
from esterified stores for steroidogenesis or excretion 
from the cell, respectively. The only known mechanism 
by which the activity of HSL is regulated is by reversible 
phosphorylation of the enzyme protein; phosphoryla- 
tion of the ‘regulatory’ site (site 1) of HSL by cyclic 
AMP-dependent protein kinase results in activation of 
the enzyme [2,7]. HSL also has a ‘basal’ phosphoryla- 
tion site (site 2) which is acted on by several protein 
kinases including .&e AMI’-activated kinase [8,9]. It ap- 
pears that phosphorylation of these two sites is mutu- 
ally exclusive; therefore if the ‘basal’ site is 
phosphoryreted then the ‘regulatory’ site is inaccessible 
to phosphorylation by the cyclic AMP-dependent pro- 
tein kinase and the enzyme cannot be activated [9]. 
Here we have demonstr&ed an additional, physiolog- 
ically relevant, mode of regulation of HSL, namely inhi- 
bition of the enzyme by oleoyl CoA, oleic acid and 
2-monopalmitoylglycerol. Two other enzymes of lipid 
metabolism, involved in fatty acid synthesis (acetyl CoA 
carboxylase) and cholesterol synthesis (HMG-CoA re- 
Correspondence address: SJ. Yeaman, Department of Biochemistry 
and Genetics, Medical School. University of Newcastle upon Tyne, 
Newcastle upon Tyne, NE2 4HH, UK. Fax: (44) (91) 222 7424. 
~bb;c?vf~io~ ES!_, ho.rmorze-sensitive lipase; CoA, coenzyme A; 
HMG-CoA, hyriroxymethylglutaryl-CoA; PNPB, p-nitrophenylbu- 
tyrate; CMC, critical miccllar concentration; PDH, pyruvate dehy- 
drogenase. 
Plrbllrhed b.v Eke&r .Scie/rce Arblishcrs B. V. 
ductase), are also subject to inhibition by olcoyl CoA 
and oleic acid, both directly [lO,l I] and via phosphoryl- 
ation by the AMP-activated kinase, which is itself acti- 
vated by an acyl CoA-dependent kinase [12]. A feed- 
back control mechanism ay therefore xist to regulate 
the tissue levels of free fatty acids and cholesterol via the 
co-ordinated regulation of the three enzymes mentioned 
above. 
2. MATERIALS AND METHODS 
2. I. Mureriuis 
HSL was prepared from bovine perirenal adipose tissue as in [l3]. 
Sources of lipid substrate, protease inhibitors and the non-ionic detcr- 
Bent C1,EIz were as described in [13]. Co-enzyme A (CoA), olcoyl 
CoA, olcic acid, 2-monopalmitoylglyccrol, cholesterol and p-nitro- 
phenylbutyrate were from Sigma. 
2.2. Ennzyme aclhicy 
HSL activity was assayed against cholesterol [‘woleate at pH 7.0 
in ethanolic suspension essentially as described in [14]. except hat 
BSA was omitted from the substrate mix. One unit of’cnzyme activity 
catalyses rhe release of I ,umol oleic acid per min. Activity against he 
water soluble substrate p-nitrophenylbutyrate (PNPB) was assayed as 
described in [I 5], assay mixtures consisting of the appropriate concen- 
tration of PNPB dissolved in I% acetonitrile in IO mM HEPES, pH 
7.0,10% (v/v) glycerol, IO mM NaCI, I mM DlT. One unit of enzyme 
activity catalyses the release of I ymol of p-nitrophcnol per minute. 
Effecters were added to enq-mc immediately prior to assaying activity; 
water-insoluble ipids were dissolved either in 0.025 vol. ethanol (for 
cholesterol c%terase assay). or 0.02 vol. acetonitrilc (for assay against 
PNPB). Controls in the absence of inhibitor were performed in the 
presence of the appropriate solvent. 
3. RESULTS AND DISCUSSION 
HSL activity against cholesterol oleate and PNPB 
WBS fourId io be IIIIIIU~L~U U> U~WJ 1,,A, c!~:c --... ..- *-L:L-r A L.. rl,,M,l P* ’ .A&! and 
2-monopalmitoylglycerol (Fig. 1). In contrast, other 
HSL reaction products, namely cholesterol and glyc- 
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Fig. 1. Inhibition of HSL by oleoyl CoA. oleic acid and 2.monopalmi- 
toylglycerol. Inhibitors were added to iISL (in 0.025 vol. ethanol) to 
give the final concentrations indicated nnd enzyme immediately as- 
sayed against cholesterol [‘Hjoleate as described in Section 2. Activi- 
ties are expressed as a percentage of controls observed in the presence 
of 0.025 vol. ethanol alone, and are mean values f S.E.M. (n = 4). 
erol, had no effect on enzyme activity (Table I). As can 
be seen in Fig. 2, oleoyl CoA inhibited the cholesterol 
esterase activity of HSL in a non-competitive manner; 
this mode of inhibition was also observed with oleic acid 
and 2-monopalmitoylglycerol (results not shown). Simi- 
lar results were obtained for inhibition of the PNPB 
hydrolysing activity of HSL (Fig. 3), suggesting that this 
water-soluble substrate is hydrolysed at the same site as 
the lipid substrate. This was further supported by the 
observation that cholesterol oleatc inhibited PNPB hy 
drolysis by HSL in a competitive manner (Fig. 4). 
Of the inhibitors examined, oleoyl CoA was found to 
Table I 
Effect of cholesterol. glycerol aad CoA on HSL activity 
Cholesterol csterase 
aclivitv (U/ml) 
PNPB hydrolasc 
activity W/ml) 
Control 1 .a4 f 0.005 4.52 zt 0.02 
Cholesterol 
5.0 /.tM I .06 f 0.005 4so ?: 0.005 
SOO~M 1.08 10.01 4.49 f 0.01 
Glycerol 
S.0 ,uM 1.03 1: 0.01 4.46 r 0.01 
500 PM I *OS zk 0.015 4.50 ?: 0.03 
CoA 
5.0 PM I .02 f o.cto5 4.48 f 0.015 
500 PM I .04 1 0.01 4.49 1- 0.02 
Effecters were added to HSL to give the final conccntrntions shown 
and resultant enzyme activity against either cholesterol [JH]oleate or 
PNPB assayed as described in Section 2. Activities are cxpressecl as 
mean values f S.E.M. (11 = 4). 
have the greatest effect, decreasing MSL activity by 50% 
at approximately 0.1 J&I (Fig. 1). Oleic acid resulted in 
50% inhibition of HSL at approximately 0.5 yM, 
whereas approximately 500 ,uM of 2-monopalmi- 
toylglycerol was required for a similar inhibition (Fig. 
1). The greater inhibition induced by oleoyl CoA cannot 
be solely attributed to the CoA moiety, as CoA alone 
was found to have no effect on the activity of HSL 
(Table I); other workers have reported that both the 
3’-phosphate moiety of CoA and the long-chain acyl 
residue are essential for inhibition of acetyl CoA car- 
boxylase by fatty acyl CoAs [lG]. 
The inhibition of HSL by oleoyl CoA and oleic acid 
was not due to any detergent effects of these com- 
pounds, as inhibition was observed at concentrations 
well below their critical micellar concentrations (CMC); 
the reported CMC for fatty acyl CoAs is 30-60 ,uM [17] 
and for fatty acids is 0.8-1.0 mM [18]. This implies that 
inhibition of HSL by oleoyl CoA and oleic acid is via 
binding to a specific site on the enzyme protein. 
Fatty acids have been reported to inhibit adenylate 
cyclase and therefore cyclic AMP accumulation in the 
adipocyte 1191. This feedback would reduce HSL activa- 
tion by phosphorylation; however, direct inhibition of 
I-ISL activity may also result from elevated levels of 
fatty acids in the cell. These two inhibitory mechanisms 
may therefore act together to prevent further accumula- 
tion of fatty acids released from lipolysis and therefore 
possible tissue damage via their detergent properties. 
The observed inhibition of HSL by 2-monopalmi- 
toylglycerol (Fig. 1) may also be of significance as a 
feedback control of lipolysis. As a result of preferential 
cleavage of l(3)-ester bonds by HSL, the hydrolysis of 
45 
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Fig. 2. Lineweaver-Burke analysis of the inhibition of HSL cholesterol 
ester%? activity by oleoyl CoA. HSL activity was assayed against 
cholesterol [“Hloleate as described in Section 2, either in the absence 
of oleoyl CoA (a) or in the presence of 1 .O yM (0), 2.5 ,uM (u), I 0 ,uM 
(A) or 50 PM (v) oleoyl CoA. A constant specific radioactivity of 
cholesterol [‘Hlolcate wus maintained ut all concentrations of the 
substrate used (approx. 2000 dpm/nmol). 
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Fig. 3. Linewcaver-Burke analysis of the inhibition of HSL activity 
against PNPB by oleoyl CoA. HSL was assayed against PNPB as 
described in Section 2, either in the absence of oleoyl CoA (0) or in 
the presence of I.OpM (0). 2.5,uM (u), IO,UM (*)or 50,~M (v) oleoyl 
CoA. Assays were performed at 30°C for20 s, with product formation 
measured by absorbance at 400 nm. 
diacylglycerol yields 2-monoacylglycerol. This is a poor 
substrate for HSL and therefore a distinct 2- 
monoacylglycerol lipase is required for the final step of 
lipolysis to yield free fatty acids and glycerol [20]. If the 
rate of production of 2-monoacylglycerol by HSL cx- 
ceeds its rate of hydrolysis by the 2-monoacylglycerol 
lipase, the resultant accumulation of the lipid may pre- 
vent its further generation. Howevsr, the physiological 
conditions under which this might occur are unknown 
as it has been reported that the 2monoacylglycerol li- 
pase is present in adipocytes in sufficient qnant.ity that 
it is not rate-limiting, even during hormonally-stimu- 
lated lipolysis [20]. 
The inhibition of HSL by fatty acyl CoAs may have 
a role in cardiac muscle where, under normal condi- 
tions, endogenous triacylglycerol is the major energy 
store [21]. However, under conditions of hypoxia and 
ischaemia, decreased coronary blood flow and oxygen 
consumption result in reduced Catty acid oxidation and 
therefore levels of fatty acyl CoAs rise [223; the cytosolic 
concentration of fatty acyl CoAs can rise to approxi- 
mately SO PM under such conditions which, as Fig. 1 
shows, is sumcient to almost completely inhibit HSL 
activity. Release of fatty acids from hydrolysis of tria- 
cylglycerol stores in the cardiomyocyte will therefore be 
significantly reduced, preventing further accumulation. 
Under such conditions the energy metabolism in the 
heart changes and stored glycogen becomes the major 
source of endogenous energy, with glucose being me- 
tabolised anaerobically to provide energy for cardiac 
function [2 11. 
Two key enzymes in fatty acid synthesis (acetyl CoA 
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Fig. 4. Lineweaver-Burke analysis of the inhibilion of HSL activily 
against PNPB by cholesterol lcate. HSL activity was assayed against 
PNPB as in the legend to Fig. 3, either in the absence of cholesterol 
oleate (0) or in the presence of 1.0 pM (o), IOpM (t) or 5OpM IA) 
cholesterol olcatc. 
carboxylase) and cholesterol synthesis (HMG-CoA re- 
ductase) are also inhibited directly by oleic acid and 
oleoyl CoA in a non-competitive manner and over sim- 
ilar concentration ranges as observed here for HSL 
[lo,1 11. All three enzymes are phosphorylated by the 
AMP-activated kinase; phosphorylation of acetyl CoA 
carboxylase and HMG-CoA reductase results in direct 
inhibition of these enzymes 1121, whereas phosphoryla- 
tion of HSL by the AMP-activated kinase blocks subse- 
quent phosphorylation and activation by cyclic AMP- 
dependent protein kinase [9]. The AMP-activated ki- 
nase is itself activated by phosphorylation by a distinct 
‘kinase-kinase’ which is activated by nanomolar con- 
centrations of fatty acyl CoA [12]. Thus a co-ordinated 
feedback mechanism may exist whereby elevated levels 
of fatty acids or fatty acyl CoAs regulate the levels of 
free cholesterol and fatty acids in the cell via inhibition 
of their synthesis or mobilisation from stores. This 
mechanism may come into effect without any detectable 
changes in the total intracellular concentration of the 
inhibitors due to their compartmentalisation, which 
may be effected by the fatty acid binding protein [Ill. 
This ‘double’ feedback mechanism of direct enzyme in- 
hibition and activation of an inhibitory kinase is also 
found in other systems. For example, NADH and acetyl 
CoA, end-products of pyruvate dehydrogenase (PDH), 
inhibit its activity both directly and via activation of 
PDH-kinase (reviewed in [23]). 
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